Microvascular dysfunction in heart failure with preserved ejection fraction: Pathophysiology, assessment, prevalence and prognosis
Bilak, Joanna McCann, Gerry Arnold, Jayanth
Bilak, Joanna
McCann, Gerry
Arnold, Jayanth
Abstract
Heart failure with preserved ejection fraction (HFpEF) currently accounts for approximately half of all new heart failure cases in the community. HFpEF is closely associated with chronic lifestyle-related diseases, such as obesity and type 2 diabetes, and clinical outcomes are worse in those with than without comorbidities. HFpEF is pathophysiologically distinct from heart failure with reduced ejection fraction, which may explain, in part, the disparity of treatment options available between the two heart failure phenotypes. The mechanisms underlying HFpEF are complex, with coronary microvascular dysfunction (MVD) being proposed as a potential key driver in its pathophysiology. In this review, the authors highlight the evidence implicating MVD in HFpEF pathophysiology, the diagnostic approaches for identifying MVD (both invasive and non-invasive) and the prevalence and prognostic significance of MVD.
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2022-07-01
Type
Article
Collections
Citation
Bilak, J. M., Alam, U., Miller, C. A., McCann, G. P., Arnold, J. R., & Kanagala, P. (2022). Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis. Cardiac failure review, 8, e24. https://doi.org/10.15420/cfr.2022.12